Language

English

Publication Date

1-1-2025

Journal

Baylor University Medical Center Proceedings

DOI

10.1080/08998280.2025.2458993

PMID

39990001

PMCID

PMC11844923

PubMedCentral® Posted Date

2-5-2025

PubMedCentral® Full Text Version

Post-print

Abstract

This study investigated erythema ab igne (EAI) and comorbid skin cancers. Each EAI case, searched by ICD-10-CM code L59.0 in the All of Us database, was compared to four controls, matched by sex at birth, age, and self-identified race/ethnicity. Demographics and skin cancer comorbidities were assessed with odds ratios (ORs) and 95% confidence intervals (CIs) using Wald’s method. EAI was most prevalent between 60 and 70 years of age. A female-to-male ratio of 1:1 was observed between ages 40 and 50. EAI patients had a statistically significant increased risk of basal cell carcinoma (OR, 10.67; 95% CI, 2.76–41.30; P <  0.001), squamous cell carcinoma (OR, 27.84; 95% CI, 1.42–545.59; P = 0.03), and melanoma (OR, 8.00; 95% CI, 1.43–44.60; P = 0.02). Additional tumors were analyzed, but insufficient case/control data was obtained from the database. In conclusion, EAI is positively correlated with skin cancers. Awareness and prevention of EAI is warranted.

Keywords

Basal cell carcinoma, case-control analysis, erythema ab igne, melanoma, skin cancer

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.